Label: DERMAZINC- pyrithione zinc spray

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated November 24, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Pyrithione Zinc 0.25%

  • KEEP OUT OF REACH OF CHILDREN

    Keep Out of Reach of Children.

  • PURPOSE

    Anti-dandruff

    Seborrheic Dermatitis treatment

  • DOSAGE & ADMINISTRATION


    Apply to affected areas twice daily or as directed by a doctor.

  • INDICATIONS & USAGE

    For relief of the symptoms of seborrheic dermatitis and dandruff.

  • WARNINGS

    Warnings
    ■ For external use only.
    ■ Ask a doctor before use if you have a condition that covers a large area of the body.

    When using this product avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with
    water.
    Stop use and ask a doctor if condition worsens or does not improve after regular use of this
    product as directed.

    If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.
    If swallowed, get medical help or contact a Poison Control Center right away.

  • INACTIVE INGREDIENT

    Isopropyl Myristate, SD-Alcohol 40-B, Sodium Lauryl Sulfate, Undecylinic Acid

  • PRINCIPAL DISPLAY PANEL

    DermaZinc Spray

  • Inner/Immediate Label

    DermaZinc Spray

  • INGREDIENTS AND APPEARANCE
    DERMAZINC 
    pyrithione zinc spray
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:35324-002
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PYRITHIONE ZINC (UNII: R953O2RHZ5) (PYRITHIONE ZINC - UNII:R953O2RHZ5) PYRITHIONE ZINC0.25 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
    UNDECYLENIC ACID (UNII: K3D86KJ24N)  
    SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
    ALCOHOL (UNII: 3K9958V90M)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:35324-002-041 in 1 BOX08/29/2022
    1120 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM03208/29/2022
    Labeler - WynnPharm Inc (620885173)
    Registrant - WynnPharm Inc (620885173)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!